Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Dec 19, 2023

BUY
$0.25 - $0.58 $37,486 - $86,968
149,945 New
149,945 $86,000
Q4 2022

Feb 15, 2023

SELL
$0.25 - $0.58 $8,508 - $19,739
-34,034 Reduced 18.5%
149,945 $87,000
Q3 2022

Nov 15, 2022

BUY
$0.3 - $0.46 $55,193 - $84,630
183,979 New
183,979 $58,000
Q2 2019

Aug 12, 2019

SELL
$4.1 - $8.05 $123,983 - $243,432
-30,240 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$5.41 - $8.73 $163,598 - $263,995
30,240 New
30,240 $248,000

Others Institutions Holding AKBA

About Akebia Therapeutics, Inc.


  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $417M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.